Determining the Effect in HIV positive men of Abacavir administration on markers of Platelet Activation
Phase of Trial: Phase IV
Latest Information Update: 08 Jun 2016
At a glance
- Drugs Abacavir (Primary)
- Indications HIV infections
- Focus Pharmacodynamics
- 10 Jun 2017 Biomarkers information updated
- 21 May 2015 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov record.
- 28 Jun 2013 Planned end date (Aug 2014) added as reported by ClinicalTrials.gov.